On our blog, you can find content curated by the VIB community. Discover our research through the eyes of our scientists.Want to be kept up-to-date on our biotechnological news and stories? Join our community and subscribe to our bi-monthly newsletter here.

VIB Blog

On our blog, you can find content curated by the VIB community. Discover our research through the eyes of our scientists.Want to be kept...

Get to know the researchers driving cutting-edge research at VIB and delve into the latest advancements in life sciences.

VIB Blog: Insights and innovations in life sciences research

Op onze blog vindt u inhoud samengesteld door de VIB-gemeenschap. Ontdek ons onderzoek door de ogen van onze wetenschappers.

Dutch

Dutch (Belgium)

English

English (Global)

#475569

On the 10th and 11th of December, the 5th edition of the Next-Generation Synthetic Biology Conference will take place in Ghent, Belgium. Earlier editions of this conference had a strong focus on Genome Engineering, while the upcoming conference will put the spotlight on Synthetic Biology. In this double interview with Prof. Tom Ellis (Imperial College London) and Prof. Sven Eyckerman (VIB-UGent Center for Medical Biotechnology), two members of the organizing committee, we deep dive into the world of Synthetic Biology, present research, and future perspectives.

Conversations with experts: engineering the future of Synthetic Biology

On the 10th and 11th of December, the 5th edition of the Next-Generation Synthetic Biology Conference will take place in Ghent, Belgium. Earlier...

Explore the gender-specific complexities of fatty liver disease and learn about potential treatments tailored to individual gender needs.

Gender-driven solutions for fatty liver disease

In a world where our health is paramount, fatty liver disease, known as metabolic dysfunction-associated steatotic liver disease (MASLD), is...

Gender personalized medicine: the future of fatty liver disease treatment

In a world where our health is paramount, fatty liver disease, known as metabolic dysfunction-associated steatotic liver disease (MASLD), is climbing the ranks of health concerns we can't afford to ignore. Imagine your liver, which controls over 500 vital functions, including the body's detox powerhouse, getting clogged with fat. Alarmingly, about 30% of people globally are wrestling against this silent epidemic. It's a complex disease with various risk factors, especially related to gender and sex hormonal differences, making a one-size-fits-all treatment difficult.

An update on CRISPR-Cas Genome editing in plants

Facts series Reviewed

In 2019, our Facts series on genome editing was published. The revolutionary technology of CRISPR-Cas took biotechnology by storm, and questions from the public started to come in. Thanks to our publication, many of these questions were answered. However, science doesn’t stand still . New techniques and applications emerge every year, with new economical and societal impacts. Politicians around the world are adapting and updating their legislations in function of these scientific evolutions. In summer 2023, the European commission will propose a new regulatory framework on genome editing. At VIB we see this as the perfect opportunity to review our Facts series from 2019 and update you on how genome editing has evolved over the past 4 years, and what a changing legislation might mean for you.

Katleen joins the VIB-UGent Center for Medical Biotechnology as new PI

Meet Katleen De Preter

By Milton Antwi and Nick Deploey, both PhD students at the lab of Karolien De Bosscher.

Medical Biotechnology

Conversations with experts: engineering the future of Synthetic Biology

Gender personalized medicine: the future of fatty liver disease treatment

An update on CRISPR-Cas Genome editing in plants

Meet Katleen De Preter

About VIB Blog

Contact